These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18463102)

  • 1. Use of the pup as the statistical unit in developmental neurotoxicity studies: overlooked model or poor research design?
    Hardy M; Stedeford T
    Toxicol Sci; 2008 Jun; 103(2):409-10; author reply 411-3. PubMed ID: 18463102
    [No Abstract]   [Full Text] [Related]  

  • 2. Anesthetic-related neurotoxicity in the developing infant: of mice, rats, monkeys and, possibly, humans.
    McGowan FX; Davis PJ
    Anesth Analg; 2008 Jun; 106(6):1599-602. PubMed ID: 18499584
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.
    Wang C; Slikker W
    Anesth Analg; 2008 Jun; 106(6):1643-58. PubMed ID: 18499593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
    Crofton KM; Foss JA; Hass U; Jensen KF; Levin ED; Parker SP
    Neurotoxicol Teratol; 2008; 30(4):266-87. PubMed ID: 17681747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: a case study of dimethoate.
    DeSesso JM; Watson RE; Keen CL; Hazelden KP; Haws LC; Li AA
    J Toxicol Environ Health A; 2009; 72(2):94-109. PubMed ID: 19034799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts.
    van Thriel C; Westerink RH; Beste C; Bale AS; Lein PJ; Leist M
    Neurotoxicology; 2012 Aug; 33(4):911-24. PubMed ID: 22008243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of neurotoxicology.
    Tilson HA
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.1. PubMed ID: 20957638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional assays for neurotoxicity testing.
    Moser VC
    Toxicol Pathol; 2011 Jan; 39(1):36-45. PubMed ID: 21075917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoride: no evidence of developmental neurotoxicity due to current exposure levels in Europe.
    Seddek AL; Ghallab A
    Arch Toxicol; 2020 Jul; 94(7):2543-2544. PubMed ID: 32583096
    [No Abstract]   [Full Text] [Related]  

  • 10. Local effects and global impact in neurotoxicity and neurodegeneration: the Xi'an International Neurotoxicology Conference.
    Fox DA; Lucchini R; Aschner M; Chen J; Anger WK; Kim EA; Boyes WK; Llorens J
    Neurotoxicology; 2012 Aug; 33(4):629-30. PubMed ID: 22609194
    [No Abstract]   [Full Text] [Related]  

  • 11. Applying the adverse outcome pathway concept to questions in anaesthetic neurotoxicity.
    Waspe J; Chico TJA; Hansen TG
    Br J Anaesth; 2021 Jun; 126(6):1097-1102. PubMed ID: 33888301
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
    Tilson HA
    Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal exposure to neurotoxic pesticides increases adult susceptibility: a review of current findings.
    Eriksson P; Talts U
    Neurotoxicology; 2000; 21(1-2):37-47. PubMed ID: 10794383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental neurotoxicity: when research succeeds through inappropriate statistics.
    Hardy M; Stedeford T
    Neurotoxicology; 2008 May; 29(3):476. PubMed ID: 18367248
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychiatric adverse reaction induced by clarithromycin.
    Negrín-González J; Peralta Filpo G; Carrasco JL; Robledo Echarren T; Fernández-Rivas M
    Eur Ann Allergy Clin Immunol; 2014 May; 46(3):114-5. PubMed ID: 24853570
    [No Abstract]   [Full Text] [Related]  

  • 16. Developmental neurotoxicity of endocrine disrupters: focus on estrogens.
    Ferguson SA; Scallet AC; Flynn KM; Meredith JM; Schwetz BA
    Neurotoxicology; 2000 Dec; 21(6):947-56. PubMed ID: 11233764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental neurotoxicity study of styrene by inhalation in Crl-CD rats.
    Cruzan G; Faber WD; Johnson KA; Roberts LS; Hellwig J; Maurissen J; Beck MJ; Radovsky A; Stump DG
    Birth Defects Res B Dev Reprod Toxicol; 2005 Jun; 74(3):221-32. PubMed ID: 15880801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
    Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
    Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication and the 3Rs: replication should be independent.
    Parton K
    Lab Anim (NY); 2008 Jan; 37(1):14. PubMed ID: 18094695
    [No Abstract]   [Full Text] [Related]  

  • 20. Developmental neurotoxicity in neonatal mice following co-exposure to PCB 153 and methyl mercury: interaction or false positive?
    Hardy ML; Stedeford T
    Toxicology; 2008 Jun; 248(2-3):160-1; author reply 162-3. PubMed ID: 18440690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.